S.NO | DATE | SPEAKER | TOPIC |
1. | 18-01-2020 | DR. A. RAMACHANDRAN | KEY TAKE WAYS FROM CAROLINA TRIAL: SU POINT OF VIEW |
2. | 20-01-2020 | DR. A. RAMACHANDRAN | LATEST GUIDELINES ON DIABETES MANAGEMENT: WHAT DOES IT MEAN IN CLINICAL PRACTICE? |
3. | 25-01-2020 | DR. A. RAMACHANDRAN | BASAL INSULIN INITIATION AND TITRATION – PATIENT CENTERED APPROACH IN INDIAN SETTINGS |
4. | 08-02-2020 | DR. A. RAMACHANDRAN | EFFICACY OF DPP4i: THE TEST OF TIME |
5. | 11-02-2020 | DR. A. RAMACHANDRAN | HYPOGLYCAEMIA AND GLYCAEMIC VARIABILITY THE LURKING SHARKS |
6. | 13-02-2020 | PROF. LESZEK CZUPRYNIAK | MEAL TIME MASTERS: INTERNATIONAL PERSPECTIVE – TREAT to TARGET WITH INSULINS IN T2DM: WHAT, WHEN & WHY? |
7. | 14-02-2020 | DR. A. RAMACHANDRAN | DIABETIC HEART DISEASE PERSONALIZED THERAPY |
8. | 20-02-2020 | DR. ARUN RAGHAVAN | INSULIN INTENSIFICATION OPTION TO CONTROL POSTPRANDIAL |
S.NO | DATE | SPEAKER | TOPIC |
1. | 12-03-19 | DR. NANDITHA ARUN | ACHIEVING GLYCEMIC CONTROL - EVOLVING NEW PRANDIAL INSULIN ANALOGUES |
2. | 01-05-19 | DR. A. RAMACHANDRAN | EMPRISE STUDY IMPLICATIONS TO PRACTICE |
3. | 06-05-19 | 3M FIRM TO ALL NURSES | CLEANING DISINFECTION & STERILIZATION |
4. | 07-05-19 | DR. NANDITHA ARUN | ACHIEVING OPTIMAL GLYCEMIC CONTROL -EVOLVING ROLE OF PRANDIAL INSULINS |
5. | 11-05-19 | DR. NANDITHA ARUN | CLINICAL EXPERIENCE WITH GLA - 300- A CASE BASED DISCUSSION |
6. | 11-05-19 | MR. VIJAY - BIOCON PHARMA | BASICS OF DIABETES COMPLICATION & INSULIN TECHNIQUES |
7. | 12-05-19 | DR. A. RAMACHANDRAN | SEETTING THE CONTEXT - MODERATOR |
8. | 23-05-19 | DR. NANDITHA ARUN | LINKING THE DOTS WITH GLP – 1RAs: T2DM, CVD AND OTHER COMORBIDITIES |
9. | 24-05-19 | DR. A. RAMACHANDRAN | CARMELINA TRIAL – EVIDENCE ON CV AND HEART FAILURE SAFETY WITH LINAGLIPTIN |
10. | 29-05-19 | DR. ARUN RAGHAVAN | PRESENT DAY APPROACH TO CV MORTALITY REDUCTION IN T2DM |
11. | 09-07-19 | DR. A. RAMACHANDRAN | CILICAL APPROCH TO CARDIO – RENAL SYNDROME IN T2DM |
12. | 09-08-19 | DR. NANDITHA ARUN | MULTI – DISCIPLINARY MANAGEMENT OF OBESITY |
13. | 16-08-19 | DR. ARUN RAGHAVAN | GLP- 1 RA: STRIVING TOWARDS AHOLOSTIC MANAGEMENT OF T2DM |
14. | 22-08-19 | DIETICIAN PRESENTATION MS. MUMTAJ MS. CHRISTINE MS. MUTHUMARI MS. PURNIMA | – PROTEIN IN OUR DIALY DIET – ROLE OF CAFFEINE IN YOUR DAILY DIET / INTERMITTENT FASTIN – SUGAR & SUGAR PRODUCTS, VEGAN DIET – GLUTEN INTOLERANCE |
15. | 28-08-19 | DR. ARUN RAGHAVAN | VERIFYING THE STATUS OF EARLY GLYCEMIC CONTROL IN T2DM |
16. | 13-09-19 | DR. NANDITHA ARUN | ACHIEVING OPTIMAL GLYCEMIC CONTROL- EVOLVING ROLE OF PRANDIAL INSULINS |
17. | 18-11-19 | DR. ARUN RAGHAVAN | SGLT2 - I AND YOU: NOVEL EMPAGLIFLOZIN REGIMENS FOR HOLISTIC CARDIOVASCULAR AND GLYCAEMIA CONTROL |
18. | 11-12-19 | DR. SANTHOSH JEYARAJ DR. LAVANYA | INITIATION OF PREMIXED INSULIN CURRENT STATUS OF SGLT2I IN T2DM & CLINICAL EVIDENCE OF REMOGLIFLOXIN |
S.NO | DATE | SPEAKER | TOPIC |
1. | 21-01-18 | DR. A. RAMACHANDRAN | DAPAGLIFLOZIN- ROLE IN TREATMENT OPTIMIZATION |
2. | 28-01-18 | DR. A. RAMACHANDRAN | LET US MEET BASAGLAR – A NEW TAKE ON INSULIN GLARGINE |
3. | 01-03-18 | DR. PRAGNA | DIABETIC FOOT ULCER WITH CELLULITIS |
4. | 01-03-18 | DR. GIRIDHAR | MATURITY ONSET OF DM OF THE YOUNG |
5. | 20-03-18 | DR. ARUN RAGHAVAN | COMBINATION THERAPY: Right from the start? |
6. | 06-04-18 | DR. ARUN RAGHAVAN | SIMPLIFYING INSULIN THERAPY FOR THE INDIAN PATIENT |
7. | 12-04-18 | MR. ANAND | BASIC LIFE SUPPORT TRAINING CLASS BY CFILS TO ALL DOCTORS |
8. | 19-04-18 | DR. KISHORE | DIABETIC NEPHROPATHY |
9. | 19-04-18 | DR. LAVANYA | CPD - FIBRO CALCULOUS PANCREATIC DIABETES |
10. | 19-04-18 | DR. ARUN RAGHAVAN | EMPOWERING CARDIO-METABOLIC OUTCOMES IN T2DM: LESSONS POST EMPA-REG OUT COME |
11. | 04-06-18 | DR. NANDITHA ARUN | COMBINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN: HERALDING AN ERA OF 360 MANAGEMENT OF T2D |
12. | 04-06-18 | DR. ARUN RAGHAVAN | EMPOWERING CARDIOMETABOLIC OUTCOMES IN T2DM: LESSONS POST EMPA-REG OUTCOME’’ |
13. | 09-06-18 | DR. MOHAMMED ZAID | GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF TYPE 2 DM |
14. | 09-06-18 | DR. SANTHOSH JEYARAJ | ROLE OF PREMIX ANALOG IN THE MANAGEMENT OF DM |
15. | 10-06-18 | DR. A. RAMACHANDRAN | CASE FROM CLINIC: A YOUNG OBESE FEMALE DIABETES PATIENTS |
16. | 20-06-18 | MR. VIVEKANANDA | NEBULIZATION & INHALATION TECHNIQUES |
17. | 23-06-18 | DR. A. RAMACHANDRAN | EMPAGLIFLOZIN/LINAGLIPTIN FDC: A LEAP TOWARDS HOLOSTIC T2D MANAGEMENT |
18. | 12-07-18 | DR. VISHANTH | METOBOLIC SYNDROME |
19. | 12-07-18 | DR. SHANMUGA PRIYA | DIABETES & PREGNANCY |
20. | 18-07-18 | DR. ARUN RAGHAVAN | FROM LEAD TO LEADER – HbA1c TO HbA1CV |
21. | 21-07-18 | DR. A. RAMACHANDRAN | DIABETES TODAY: PUTTING EVIDENCE INTO PRACTICE |
22. | 27-07-18 | DR. NANDITHA ARUN | EVOLVING TREATMENT OPTIONS FOR PATIENTS WITH TYPE 2 DIABETES: STRIKING THE RIGHT BALANCE WITH NEWER INSULIN CO- FORMULATION |
23. | 28-07-18 | DR. A. RAMACHANDRAN | DAWNING THE SPLENDOUR OF CARDIOPROTECTION IN DIABETES |
24. | 02-08-18 | DR. K. V. ARUN | PERIODONTAL DISEASE & DIABETES – BIDIRECTIONAL RELATIONSHIP |
25. | 02-08-18 | DR. P.D. MADAN KUMAR | ORAL CASE FOR DIABETES PATIENT – RECENT CONCEPTS |
26. | 04-08-18 | DR. A. RAMACHANDRAN | COMPARING SECOND GENERATION BASAL INSULINS : A SPOTLIGHT ON THE BRIGHT STUDY |
27. | 10-08-18 | DR. A. RAMACHANDRAN | INSULINS HAVE BECOME PATIENT FRIENDLY: MAKING TIMELY INSULIN INITIATION A REALITY |
28. | 17-08-18 | DR. ARUN RAGHAVAN | I AM RISKING MY PATIENTS BY DELAYING INSULINIZATION |
29. | 26-09-18 | DR. ARUN RAGHAVAN | WE LOOK FORWARD TO YOUR ESTEEMED PRESENCE AND PARTICIPATION! |
30. | 11-10-18 | DR. NANDITHA ARUN | COMPARING SECOND GENERATION BASAL INSULINS : A SPOTLIGHT ON THE BRIGHT STUDY |
31. | 21-10-18 | DR. A. RAMACHANDRAN | M. HEALTH: EMERGENCE OF NEW SCIENCE FOR DIABETES CARE AND PREVENTION |
32. | 26-10-18 | DR. A. RAMACHANDRAN | CLINICAL IMPACT OF INITIATING INSULIN EARLY- ARE WE JUSTIFIED IN THE DELAY |
33. | 11-11-18 | DR. ARUN RAGHAVAN | BASAL INSULIN CIRCLE |
34. | 15-11-18 | DR. SANTHOSH JEYARAJ | LOGICAL CHOICE OF OAD: EMPHASIS ON GLIPTINS |
35. | 19-11-18 | DR. A. RAMACHANDRAN | CV AND RENAL CO-MORBIDITIES WITH DIABETES: ELEPHANTS IN THE ROOM |
36. | 28-11-18 | DR. NANDITHA ARUN | STENO – A TALE TO TELL |
37. | 09-12-18 | DR. ARUN RAGHAVAN | INSULIN INITIATION IN T2DM PATIENTS INADEQUATELY CONTROLLED ON OADs |
38. | 14-12-18 | DR. NANDITHA ARUN | PRESENT DAY APPROACH TO CV MORTALITY REDUCTION IN T2DM |
39. | 28-12-18 | DR. NANDITHA ARUN | INSTRIDE 1 AND 2 SAFETY AND EFFICACY OF BIOCON INSULIN OTHER REFERENCE GLARGINE |
S.NO | DATE | SPEAKER | TOPIC |
1. | 02-03-17 | MS. LANVANYA & MS. LAGNA | ROLE OF OILS & NUTS IN ONE’S DIET |
2. | 20-04-17 | MS. GIFTA | FRUITS & VEGETABLES |
3. | 11-05-17 | MS. SATHYA | NURSES & COMMUNICATION |
4. | 11-05-17 | MS. ABIRAMY | NURSING SERVICE & HOLISTIC APPROACH |
5. | 11-05-17 | MR. ANAND | A VOICE OF LEAD-NURSES DAY THEME 2017 |
6. | 06-08-17 | DR. NANDITHA ARUN | PREVENTION OF DIABETES - AN UPDATE |
7. | 20-08-17 | DR. A. RAMACHANDRAN | DIABETES 360: EXPERTS VIEW ON MANAGING DIABETES COMPLICATIONS |
8. | 07-09-17 | MS. NITHYASHRI | NUTRITIONAL SUPPORT IN YOUNG CHILDREN & TYPE 1 DM |
9. | 20-09-17 | DR. ARUN RAGHAVAN | BASAL OPTIMIZATION WITH GLP-I ANALOGUE |
10. | 23-09-17 | DR. A. RAMACHANDRAN | INDIAN PATIENT OF T2DM: WHAT DOES EVIDENCE MEAN TO CLINICAL PRACTICE? |
11. | 21-10-17 | DR. HENRI FROM FINLAND | SLEEP DISORDER OF DIABETES |
12. | 21-10-17 | DR. SANTHOSH JEYARAJ | ASK THE EXPERT-OVERWEIGHT OR MAJORITY-RIGHT PATIENT FOR SGLT2i |
13. | 16-11-17 | DR. VAIBHAV | CASE PRESENTATION – TYPE 1 DM & HTN |
14. | 16-11-17 | DR. BHAMA | CASE PRESENTATION – DIABETIC FOOT INFECTION |
15. | 22-12-17 | DR. A. RAMACHANDRAN | CLINICAL IMPACT OF INITIATING INSULIN EARLY |
16. | 22-12-17 | DR. ARUN RAGHAVAN | INITIATING INSULIN THERAPY: CLINICAL BENEFITS OF NEW INSULIN CO -FORMULATION |
17. | 23-12-17 | DR. ARUN RAGHAVAN | EMERGING ROLE OF GLP1 ANALOQUSE IN T2DM: CARDIOVASCULAR AND RENAL OUTCOMES |
S.NO | DATE | SPEAKER | TOPIC |
1. | 25-01-16 | DR. PETER LIN | METABOLIC STATE IN INDIAN TYPE 2 DIABETES |
2. | 28-07-16 | DR. CHANDRASEKARAN | RENAL SPECIFIC NUTRITION |
3. | 20-02-16 | DR. NANDITHA ARUN | CANAGLIFLOXIN: PLACE IN THERAPY FOR INDIAN DIABETICS |
4. | 23-02-16 | DR. NANDITHA ARUN | IMPROVING METABOLIC STATE IN TYPE 2 DIABETES WITH SGLT2i |
5. | 28-02-16 | DR. ARUN RAGHAVAN | IMPROVING METABOLIC STATE IN TYPE 2 DIABETES WITH SGLT2i |
6. | 03-12-16 | DR. NANDITHA ARUN | OVERCOMING CHALLENGES IN HYPERGLYCEMIC MANAGEMENT |
7. | 22-04-16 | DR. NANDITHA ARUN | TRULICITY LAUNCH |
8. | 05-07-16 | DR. ARUN RAGHAVAN | ADVANCING DIABETES CARE WITH GLP-1 RECEPTOR AGONISTS |
9. | 01-12-16 | Dr. A. RAMACHANDRAN | RESOLVING HBA1C PARADOX IN MANAGEMENT OF TYPE 2 DIABETES |
10. | 23-01-16 | Dr. A. RAMACHANDRAN | CAN WE CHANGE THE HISTORY OF TYPE 2 DIABETES |
11. | 30-01-16 | Dr. A. RAMACHANDRAN | SGLT2I – NEW PARADIGM IN DIABETES |
12. | 02-07-16 | Dr. A. RAMACHANDRAN | ASIAN INDIANS - ARE WE DIFFERENT? |
13. | 03-03-16 | Dr. A. RAMACHANDRAN | TRULICITY LAUNCH MEETING |
14. | 15-05-16 | Dr. A. RAMACHANDRAN | CARDIOVASCULAR RISK MANAGEMENT IN DIABETES |
S.NO | DATE | SPEAKER | TOPIC |
1. | 02-12-15 | DR. G. MANOHARAN, PLASTIC SURGEON | DIABETIC FOOT ULCER |
2. | 19-03-15 | DR. NIVIEN | DIABETIC RETINOPATHY |
3. | 04-02-15 | DR. RAM JAGANATHAN | ROUTINE PREDICTION OF TYPE 2 DIABETES |
4. | 04-02-15 | DR. SELVAM | PREVENTION OF TYPE 2 DIABETES |
5. | 04-06-15 | DR. UMA MAHESH | GLP ANALOGUES IN TYPE 2 DIABETES |
6. | 04-06-15 | DR. SANTHOSH JAYARAJ | DPP4 INHIBITORS IN TYPE 2 DIABETES |
7. | 23-06-15 | MARY CATHERIN | OVERVIEW OF PROJECTS IMPLEMENTATION |
8. | 13-08-15 | DR. GIRISH | ROLE OF PLASTIC SURGEON IN DIABETES |
9. | 20-08-15 | DR. T. M.BA LAKRISHNAN | MICROVASCULAR RECONSTRUCTION IN REVASCULARISED DIABETIC FOOT |
10. | 20-06-15 | DR. NANDITHA ARUN | WHAT AFTER METFORMIN : CANAGLIPTOSIS |
11. | 21-06-15 | DR. NANDITHA ARUN | ARE WESTERN GUIDELINES FOR DIABETES & DYSLIPIDEMIA HELPING OUR PATIENTS? |
12. | 26-06-15 | DR. NANDITHA ARUN | EMERGING ROLE OF THE KIDNEY AS A TARGET OF THERAPY |
13. | 15-07-15 | DR. NANDITHA ARUN | GLYCEMIC VARIABILITY |
14. | 20-06-15 | DR. NANDITHA ARUN | WHAT AFTER METFORMIN : CANAGLIPTOSIS |
15. | 21-06-15 | DR. NANDITHA ARUN | ARE WESTERN GUIDELINES FOR DIABETES & DYSLIPIDEMIA HELPING OUR PATIENTS? |
16. | 26-06-15 | DR. NANDITHA ARUN | EMERGING ROLE OF THE KIDNEY AS A TARGET OF THERAPY |
17. | 15-07-15 | DR. NANDITHA ARUN | GLYCEMIC VARIABILITY |
S.NO | DATE | SPEAKER | TOPIC |
1. | 20-03-14 | Dr. V. B. NARAYANA MURTHY | SCOPE AND DEATH OF PLASTIC SURGERY IN PREVENTION OF DIABETIC FOOT ULCERS |
2. | 04-01-14 | Dr. ARAVINDAN SELVARAJ | DIABETIC PERIARTHRITIS IS A SURGICAL DISEASE |
3. | 08-05-14 | Dr. ARAVINDAN SELVARAJ | GLYCAEMIC CONTROL IN ICU'S |
4. | 31-07-14 | Dr. LATHA DULIPRINGH | OSTEOPOROSIS, FRACTURES & BEYOND |
5. | 21-08-14 | Dr. PRITHIKA CHARY | NEUROLOGICAL MANIFESTATIONS IN DIABETES |
6. | 25-09-14 | Prof. M. MADHAVAN | CURRENT CONCEPTS ON THE USE OF ORAL HYPOGLYCEMIC AGENT |
7. | 18-04-14 | Dr. S. SUBRAMANIAN | PNEUMOCOCCAL VACCINATION IN SPECIAL POPULATION |
8. | 16-10-14 | Dr. PANEERSELVAM | INTERESTING CARE STUDIES IN DIABETES |